SLP's recent trajectory suggests a business in transition: revenue growth slowed to 7.5% in 2026Q3 from the 22-30% pace printed through mid-2025, while gross margin recovered to 69.1% from a 36.6% trough in 2024Q4, implying profitability is highly sensitive to service mix rather than structural pricing.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Jul 9, 2026 | $0.30+29.0% vs $0.23 | $22M+4.7% vs $21M |
Q2 2026 Apr 9, 2026 | $0.35+29.6% vs $0.27 | $24M+12.2% vs $22M |
Q1 2026 Jan 8, 2026 | $0.13-27.8% vs $0.18 | $18M+2.0% vs $18M |
Q4 2025 Dec 1, 2025 | $0.10+0.0% vs $0.10 | $17M+0.4% vs $17M |
SAN DIEGO, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating Simulations Plus, Inc. (NASDAQ: SLP) for investors who suffered losses and whether they may recover those losses under federal securities laws.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced a funded partnership with a global large pharmaceutical company to apply Turin, its AI-enabled scientific engine for quantitative systems pharmacology (QSP), within an active therapeutic development program. The collaboration will evaluate how AI-enabled.
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the completion of its acquisition by affiliates of Altaris, LLC ("Altaris"), an investment firm focused exclusively on the healthcare industry.The transaction was originally announced on June 16, 2026. At the effective time of the merger each Simulations.
Shares of Simulations Plus, Inc. (NASDAQ: SLP - Get Free Report) crossed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $16.21 and traded as high as $18.42. Simulations Plus shares last traded at $18.42, with a volume of 104,375 shares. Wall Street Analysts Forecast Growth A
Benchmark SLP against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Simulations Plus, Inc. (SLP)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $18.50 | $374.16M | -5.75 | 13.09% | -81.74% | -42.13% | — | |
| $303.73 | $49.34B | 55.83 | 16.34% | 29.34% | 14% | — | |
| $12.05 | $1.87B | -1205.00 | 8.75% | -16.75% | -6.66% | — | |
| $3.50 | $22.01M | -2.57 | 449.95% | -53.27% | -21.1% | — | |
| $10.21 | $637.69M | -8.37 | — | — | -34.03% | — | |
| $29.82 | $2.23B | -21.15 | 23.29% | -20.98% | -16.37% | — |
Simulations Plus, Inc. (SLP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Simulations Plus, Inc. (SLP) SEC filings — annual & quarterly reports (10-K, 10-Q)
Jul 9, 2026·SEC
Jun 17, 2026·SEC
Jun 16, 2026·SEC
Get notified when SLP posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Simulations Plus, Inc. (SLP) stock FAQ — growth, dividends, profitability & financials explained
Simulations Plus, Inc. (SLP) reported $82.1M in revenue over the trailing twelve months. Revenue was $79.2M in fiscal year 2025. That is 2945% more than the $2.6M of fiscal year 1996.
Simulations Plus, Inc. (SLP) grew revenue by 13.1% in fiscal year 2025, compared with the prior fiscal year.
Yes. Simulations Plus, Inc. (SLP) earned $8.1M in net income over the trailing twelve months (a 9.9% net margin).
Simulations Plus, Inc. (SLP) had a return on equity (ROE) of -42.1% in fiscal year 2025. A negative ROE means the company lost money over the period.
Simulations Plus, Inc. (SLP) generated $26.1M in free cash flow over the trailing twelve months.
